{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "# !pip install langchain==0.0.346\n",
    "# !pip install newspaper3k==0.2.8\n",
    "# !pip install pandas==2.1.3\n",
    "# !pip install deltalake==0.14.0\n",
    "# !pip install tabulate==0.9.0\n",
    "# !pip install googlenews\n",
    "# !pip install gnews==0.3.6\n",
    "# !pip install plotly==5.18.0\n",
    "# ! pip install nbformat==5.9.2\n",
    "# !pip install openai==1.3.7\n",
    "# !pip show "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import sys\n",
    "sys.path.append('..')\n",
    "\n",
    "import os\n",
    "import json\n",
    "import pandas as pd\n",
    "\n",
    "from tabulate import tabulate\n",
    "from IPython.display import display, Markdown\n",
    "# TEST\n",
    "\n",
    "from datetime import datetime, timedelta\n",
    "import pytz\n",
    "\n",
    "from deltalake import DeltaTable\n",
    "from deltalake.writer import write_deltalake\n",
    "\n",
    "from openai import OpenAI\n",
    "\n",
    "OPENAI_API_KEY = os.getenv('OPENAI_API_KEY')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "    end_date: 2023-12-07\n",
      "    start_date: 2023-10-08\n",
      "    \n",
      "    \n",
      "    days_lookback: 60\n",
      "    max_results: 1000\n",
      "    \n",
      "Harambe was here\n"
     ]
    }
   ],
   "source": [
    "# Params\n",
    "table_path = '../data/articles-ingest'\n",
    "\n",
    "# --------------------------------------------\n",
    "query = \"Ozempic Eli Lilly\"\n",
    "\n",
    "days_lookback = 30*2\n",
    "max_results = 1000\n",
    "current_datetime = datetime.now().astimezone(pytz.utc)\n",
    "current_date = current_datetime.date()\n",
    "start_date = (current_datetime - timedelta(days=days_lookback)).date()\n",
    "\n",
    "# --------------------------------------------\n",
    "\n",
    "start_date_str = str(start_date.strftime(\"%Y-%m-%d\"))\n",
    "current_date_str = str(current_date.strftime(\"%Y-%m-%d\"))\n",
    "\n",
    "print(\n",
    "    f\"\"\"\n",
    "    end_date: {current_date}\n",
    "    start_date: {start_date}\n",
    "    \n",
    "    \n",
    "    days_lookback: {days_lookback}\n",
    "    max_results: {max_results}\n",
    "    \"\"\"\n",
    ")\n",
    "\n",
    "print(\"Harambe was here\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "query            \n",
       "Return to Office     97\n",
       "Ozempic              89\n",
       "Ozempic Eli Lilly    84\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Query queries that have been ingested\n",
    "DeltaTable(table_path).to_pandas(columns=['query']).value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>title</th>\n",
       "      <th>description</th>\n",
       "      <th>published date</th>\n",
       "      <th>url</th>\n",
       "      <th>publisher</th>\n",
       "      <th>query</th>\n",
       "      <th>query end date</th>\n",
       "      <th>published datetime</th>\n",
       "      <th>published date str</th>\n",
       "      <th>article text</th>\n",
       "      <th>article html</th>\n",
       "      <th>article summary</th>\n",
       "      <th>article keywords</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Eli Lilly Just Got One Step Closer to Dethroni...</td>\n",
       "      <td>Eli Lilly Just Got One Step Closer to Dethroni...</td>\n",
       "      <td>2023-11-19</td>\n",
       "      <td>https://news.google.com/rss/articles/CBMiXWh0d...</td>\n",
       "      <td>{'href': 'https://www.fool.com', 'title': 'The...</td>\n",
       "      <td>Ozempic Eli Lilly</td>\n",
       "      <td>2023-12-07 02:38:25.798191</td>\n",
       "      <td>2023-11-19 08:00:00</td>\n",
       "      <td>2023-11-19</td>\n",
       "      <td>Just about every evening when I sit down for d...</td>\n",
       "      <td>\\n\\n&lt;!DOCTYPE html&gt;\\n&lt;html lang=\"en\" prefix=\"o...</td>\n",
       "      <td>Let's break down what Eli Lilly has in its pip...</td>\n",
       "      <td>[step, eli, closer, drug, lilly, ozempic, buy,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Ozempic Sales Are Skyrocketing Faster Than Exp...</td>\n",
       "      <td>Ozempic Sales Are Skyrocketing Faster Than Exp...</td>\n",
       "      <td>2023-10-17</td>\n",
       "      <td>https://news.google.com/rss/articles/CBMiXWh0d...</td>\n",
       "      <td>{'href': 'https://www.fool.com', 'title': 'The...</td>\n",
       "      <td>Ozempic Eli Lilly</td>\n",
       "      <td>2023-12-07 02:38:25.798191</td>\n",
       "      <td>2023-10-17 07:00:00</td>\n",
       "      <td>2023-10-17</td>\n",
       "      <td>Everything seems to be going right for Novo No...</td>\n",
       "      <td>\\n\\n&lt;!DOCTYPE html&gt;\\n&lt;html lang=\"en\" prefix=\"o...</td>\n",
       "      <td>Ozempic sales are skyrocketing faster than exp...</td>\n",
       "      <td>[expected, drug, skyrocketing, lilly, ozempic,...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                               title  \\\n",
       "0  Eli Lilly Just Got One Step Closer to Dethroni...   \n",
       "1  Ozempic Sales Are Skyrocketing Faster Than Exp...   \n",
       "\n",
       "                                         description published date  \\\n",
       "0  Eli Lilly Just Got One Step Closer to Dethroni...     2023-11-19   \n",
       "1  Ozempic Sales Are Skyrocketing Faster Than Exp...     2023-10-17   \n",
       "\n",
       "                                                 url  \\\n",
       "0  https://news.google.com/rss/articles/CBMiXWh0d...   \n",
       "1  https://news.google.com/rss/articles/CBMiXWh0d...   \n",
       "\n",
       "                                           publisher              query  \\\n",
       "0  {'href': 'https://www.fool.com', 'title': 'The...  Ozempic Eli Lilly   \n",
       "1  {'href': 'https://www.fool.com', 'title': 'The...  Ozempic Eli Lilly   \n",
       "\n",
       "              query end date  published datetime published date str  \\\n",
       "0 2023-12-07 02:38:25.798191 2023-11-19 08:00:00         2023-11-19   \n",
       "1 2023-12-07 02:38:25.798191 2023-10-17 07:00:00         2023-10-17   \n",
       "\n",
       "                                        article text  \\\n",
       "0  Just about every evening when I sit down for d...   \n",
       "1  Everything seems to be going right for Novo No...   \n",
       "\n",
       "                                        article html  \\\n",
       "0  \\n\\n<!DOCTYPE html>\\n<html lang=\"en\" prefix=\"o...   \n",
       "1  \\n\\n<!DOCTYPE html>\\n<html lang=\"en\" prefix=\"o...   \n",
       "\n",
       "                                     article summary  \\\n",
       "0  Let's break down what Eli Lilly has in its pip...   \n",
       "1  Ozempic sales are skyrocketing faster than exp...   \n",
       "\n",
       "                                    article keywords  \n",
       "0  [step, eli, closer, drug, lilly, ozempic, buy,...  \n",
       "1  [expected, drug, skyrocketing, lilly, ozempic,...  "
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = DeltaTable(table_path).to_pandas(\n",
    "    filters=[\n",
    "        ('query','=',query),\n",
    "        ('published date str','>', start_date_str),\n",
    "    ]\n",
    ")\n",
    "\n",
    "df = df.loc[df['article text'].notna()] # can remove articles where scraping failed\n",
    "\n",
    "df.head(2)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## process for prompting openai with article info, with traceability\n",
    "\n",
    "- Each row in the table is an article. Functions can be used to iterate through the table and add additional column.\n",
    "- For each prompt, we want to retain the prompt in the table, as well as the message history, and response.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "client = OpenAI()\n",
    "\n",
    "def print_df(df):\n",
    "    return tabulate(df, headers='keys', tablefmt='html')\n",
    "\n",
    "def generate_openai_response_json(prompt, model=\"gpt-3.5-turbo-1106\"):\n",
    "    \"\"\"\n",
    "    Generic function to generate a GPT response\n",
    "    \"\"\"\n",
    "    response = client.chat.completions.create(\n",
    "    model=model,\n",
    "    response_format={ \"type\": \"json_object\" },\n",
    "    messages=[\n",
    "        {\"role\": \"system\", \"content\": \"You are a helpful assistant designed to output JSON.\"},\n",
    "        {\"role\": \"user\", \"content\": prompt}\n",
    "    ]\n",
    "    )\n",
    "    json_response = response.choices[0].message.content\n",
    "    return json.loads(json_response)\n",
    "\n",
    "\n",
    "\n",
    "def generate_sentiment_prompt(query, title, article_text, published_date_str):\n",
    "    prompt = f\"\"\"\n",
    "    # You are a reviewer of articles. \n",
    "    - Your task is to read the article below, provide a sentiment negativity score.\n",
    "    - 0 is very positive, 10 is very negative.\n",
    "    - Please provide short bullet points, each representing specific negative claims made in the article (if any).\n",
    "\n",
    "    ## Inputs\n",
    "    - Search term used to find this article: {query}\n",
    "\n",
    "    - The article:\n",
    "        - Title: {title}\n",
    "        - Published Date: {published_date_str}\n",
    "        - Article: \\n{article_text}\n",
    "\n",
    "    ## Outputs\n",
    "    Please return the output as a JSON object with the following: sentiment_score (int in string format), sentiment_explanation (string), and negative_claims (string with bullet points delimited by new lines), \n",
    "    \"\"\"\n",
    "    return prompt\n",
    "\n",
    "def generate_sentiment_prompt_and_response(query, title, article_text, published_date_str):\n",
    "    \n",
    "    sentiment_prompt = generate_sentiment_prompt(query, title, article_text, published_date_str)\n",
    "\n",
    "    response = generate_openai_response_json(sentiment_prompt)\n",
    "    return response['sentiment_score'], response['sentiment_explanation'], response['negative_claims']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "i=2\n",
    "article_text = df.iloc[i]['article text']\n",
    "published_date_str = df.iloc[i]['published date str']\n",
    "title = df.iloc[i]['title']\n",
    "query = df.iloc[i]['query']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/markdown": [
       "\n",
       "    # You are a reviewer of articles. \n",
       "    - Your task is to read the article below, provide a sentiment negativity score.\n",
       "    - 0 is very positive, 10 is very negative.\n",
       "    - Please provide short bullet points, each representing specific negative claims made in the article (if any).\n",
       "\n",
       "    ## Inputs\n",
       "    - Search term used to find this article: Ozempic Eli Lilly\n",
       "\n",
       "    - The article:\n",
       "        - Title: Will Ozempic-type obesity drugs pay off for society? Makers say yes - STAT\n",
       "        - Published Date: 2023-10-17\n",
       "        - Article: \n",
       "Our expensive obesity drugs are worth it, Novo Nordisk and Eli Lilly argue in raft of studies\n",
       "\n",
       "DALLAS — Here at ObesityWeek, one of the largest conferences on obesity, Novo Nordisk and Eli Lilly are displaying more than a dozen studies that together carry the message: Our blockbuster weight loss treatments will be worth it for society.\n",
       "\n",
       "But experts point out that much of this company-funded research does not include the cost of the drugs themselves, which sell at more than $10,000 per year in the U.S. and are meant to be taken indefinitely.\n",
       "\n",
       "advertisement\n",
       "\n",
       "The two major pharmaceutical companies have seen interest skyrocket for their GLP-1-based drugs like Ozempic, Wegovy, and Mounjaro, a new generation of medications that can cut substantial amounts of weight. But insurance plans have been slow to grant wide access to obesity treatments, concerned that the vast amount of people eligible to take them, along with their high price, could lead to significant financial strain.\n",
       "\n",
       "    ## Outputs\n",
       "    Please return the output as a JSON object with the following: sentiment_score (int in string format), sentiment_explanation (string), and negative_claims (string with bullet points delimited by new lines), \n",
       "    "
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sentiment_prompt = generate_sentiment_prompt(query, title, article_text, published_date_str)\n",
    "display(Markdown(sentiment_prompt))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sentiment_score: 7\n",
      "sentiment_explanation: The sentiment negativity score is 7, indicating a fairly negative sentiment towards the cost and access to obesity drugs.\n",
      "negative_claims: - Company-funded research does not include the cost of the drugs themselves\n",
      "- High price of the drugs, selling at more than $10,000 per year in the U.S.\n",
      "- Insurance plans have been slow to grant wide access to obesity treatments due to concerns over significant financial strain\n"
     ]
    }
   ],
   "source": [
    "sentiment_score, sentiment_explanation, negative_claims = generate_sentiment_prompt_and_response(query, title, article_text, published_date_str)\n",
    "\n",
    "print(f\"sentiment_score: {sentiment_score}\")\n",
    "print(f\"sentiment_explanation: {sentiment_explanation}\")\n",
    "print(f\"negative_claims: {negative_claims}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_results = df.apply(lambda row: generate_sentiment_prompt_and_response(row['query'], row['title'], row['article text'], row['published date str']), axis=1, result_type='expand')\n",
    "df_results.columns = ['sentiment_score', 'sentiment_explanation', 'negative_claims']\n",
    "\n",
    "df_results['sentiment_score'] = df_results['sentiment_score'].astype(int)\n",
    "\n",
    "df = pd.concat([df,df_results], axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "df = df.sort_values(by=['sentiment_score'], ascending=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>title</th>\n",
       "      <th>description</th>\n",
       "      <th>published date</th>\n",
       "      <th>url</th>\n",
       "      <th>publisher</th>\n",
       "      <th>query</th>\n",
       "      <th>query end date</th>\n",
       "      <th>published datetime</th>\n",
       "      <th>published date str</th>\n",
       "      <th>article text</th>\n",
       "      <th>article html</th>\n",
       "      <th>article summary</th>\n",
       "      <th>article keywords</th>\n",
       "      <th>sentiment_score</th>\n",
       "      <th>sentiment_explanation</th>\n",
       "      <th>negative_claims</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>Pfizer struggles to catch up to Ozempic, Wegov...</td>\n",
       "      <td>Pfizer struggles to catch up to Ozempic, Wegov...</td>\n",
       "      <td>2023-12-02</td>\n",
       "      <td>https://news.google.com/rss/articles/CBMidmh0d...</td>\n",
       "      <td>{'href': 'https://www.latimes.com', 'title': '...</td>\n",
       "      <td>Ozempic Eli Lilly</td>\n",
       "      <td>2023-12-07 02:38:25.798191</td>\n",
       "      <td>2023-12-02 11:00:39</td>\n",
       "      <td>2023-12-02</td>\n",
       "      <td>On Friday, Pfizer announced that it’s dropping...</td>\n",
       "      <td>&lt;!DOCTYPE html&gt;&lt;html class=\"page article-page\"...</td>\n",
       "      <td>On Friday, Pfizer announced that it’s dropping...</td>\n",
       "      <td>[pills, catch, ozempic, struggles, experienced...</td>\n",
       "      <td>8</td>\n",
       "      <td>The article portrays a negative sentiment towa...</td>\n",
       "      <td>- Pfizer is dropping development of an experim...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>Woman dies after taking Ozempic to slim down f...</td>\n",
       "      <td>Woman dies after taking Ozempic to slim down f...</td>\n",
       "      <td>2023-11-06</td>\n",
       "      <td>https://news.google.com/rss/articles/CBMiYWh0d...</td>\n",
       "      <td>{'href': 'https://nypost.com', 'title': 'New Y...</td>\n",
       "      <td>Ozempic Eli Lilly</td>\n",
       "      <td>2023-12-07 02:38:25.798191</td>\n",
       "      <td>2023-11-06 08:00:00</td>\n",
       "      <td>2023-11-06</td>\n",
       "      <td>An Australian woman who took Ozempic to shed a...</td>\n",
       "      <td>&lt;!doctype html&gt;\\n&lt;html lang=\"en-US\"&gt;\\n\\n&lt;head ...</td>\n",
       "      <td>Intestinal blockage is called “ileus” — the FD...</td>\n",
       "      <td>[daughters, drug, shouldnt, woman, minutes, 60...</td>\n",
       "      <td>8</td>\n",
       "      <td>The sentiment negativity score for the article...</td>\n",
       "      <td>- Use of Ozempic led to the death of a woman\\n...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>Anti-obesity drugs Ozempic and Mounjaro can sh...</td>\n",
       "      <td>Anti-obesity drugs Ozempic and Mounjaro can sh...</td>\n",
       "      <td>2023-10-24</td>\n",
       "      <td>https://news.google.com/rss/articles/CBMihQFod...</td>\n",
       "      <td>{'href': 'https://english.elpais.com', 'title'...</td>\n",
       "      <td>Ozempic Eli Lilly</td>\n",
       "      <td>2023-12-07 02:38:25.798191</td>\n",
       "      <td>2023-10-24 07:00:00</td>\n",
       "      <td>2023-10-24</td>\n",
       "      <td>Starry-eyed venture capitalists love to talk a...</td>\n",
       "      <td>&lt;!DOCTYPE html&gt;&lt;html lang=\"en-us\"&gt;&lt;head&gt;&lt;scrip...</td>\n",
       "      <td>New anti-obesity drugs have the potential to t...</td>\n",
       "      <td>[medical, antiobesity, ozempic, mounjaro, reve...</td>\n",
       "      <td>8</td>\n",
       "      <td>The article discusses potential negative impac...</td>\n",
       "      <td>- New anti-obesity drugs have the potential to...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Novo Nordisk to reduce supply of Victoza to ma...</td>\n",
       "      <td>Novo Nordisk to reduce supply of Victoza to ma...</td>\n",
       "      <td>2023-11-22</td>\n",
       "      <td>https://news.google.com/rss/articles/CBMicmh0d...</td>\n",
       "      <td>{'href': 'https://www.fiercepharma.com', 'titl...</td>\n",
       "      <td>Ozempic Eli Lilly</td>\n",
       "      <td>2023-12-07 02:38:25.798191</td>\n",
       "      <td>2023-11-22 08:00:00</td>\n",
       "      <td>2023-11-22</td>\n",
       "      <td>Unable to scale up its manufacturing fast enou...</td>\n",
       "      <td>&lt;!DOCTYPE html&gt;\\n&lt;html lang=\"en\" dir=\"ltr\" pre...</td>\n",
       "      <td>Unable to scale up its manufacturing fast enou...</td>\n",
       "      <td>[shortage, drug, production, boost, quarter, o...</td>\n",
       "      <td>8</td>\n",
       "      <td>The article contains several negative claims a...</td>\n",
       "      <td>Novo Nordisk facing shortage of Victoza\\nReduc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>Pfizer's stock falls 6% after halting trial of...</td>\n",
       "      <td>Pfizer's stock falls 6% after halting trial of...</td>\n",
       "      <td>2023-12-01</td>\n",
       "      <td>https://news.google.com/rss/articles/CBMihgFod...</td>\n",
       "      <td>{'href': 'https://www.morningstar.com', 'title...</td>\n",
       "      <td>Ozempic Eli Lilly</td>\n",
       "      <td>2023-12-07 02:38:25.798191</td>\n",
       "      <td>2023-12-01 15:20:00</td>\n",
       "      <td>2023-12-01</td>\n",
       "      <td>By Ciara Linnane\\n\\nPfizer says it will not mo...</td>\n",
       "      <td>&lt;!doctype html&gt;\\n&lt;html data-n-head-ssr lang=\"e...</td>\n",
       "      <td>The stock was on track for its biggest one-day...</td>\n",
       "      <td>[drug, dow, danuglipron, jones, eli, halting, ...</td>\n",
       "      <td>7</td>\n",
       "      <td>The sentiment negativity score for the article...</td>\n",
       "      <td>- Pfizer's stock tumbled 6%\\n- Pfizer's stock ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                title  \\\n",
       "34  Pfizer struggles to catch up to Ozempic, Wegov...   \n",
       "40  Woman dies after taking Ozempic to slim down f...   \n",
       "36  Anti-obesity drugs Ozempic and Mounjaro can sh...   \n",
       "15  Novo Nordisk to reduce supply of Victoza to ma...   \n",
       "33  Pfizer's stock falls 6% after halting trial of...   \n",
       "\n",
       "                                          description published date  \\\n",
       "34  Pfizer struggles to catch up to Ozempic, Wegov...     2023-12-02   \n",
       "40  Woman dies after taking Ozempic to slim down f...     2023-11-06   \n",
       "36  Anti-obesity drugs Ozempic and Mounjaro can sh...     2023-10-24   \n",
       "15  Novo Nordisk to reduce supply of Victoza to ma...     2023-11-22   \n",
       "33  Pfizer's stock falls 6% after halting trial of...     2023-12-01   \n",
       "\n",
       "                                                  url  \\\n",
       "34  https://news.google.com/rss/articles/CBMidmh0d...   \n",
       "40  https://news.google.com/rss/articles/CBMiYWh0d...   \n",
       "36  https://news.google.com/rss/articles/CBMihQFod...   \n",
       "15  https://news.google.com/rss/articles/CBMicmh0d...   \n",
       "33  https://news.google.com/rss/articles/CBMihgFod...   \n",
       "\n",
       "                                            publisher              query  \\\n",
       "34  {'href': 'https://www.latimes.com', 'title': '...  Ozempic Eli Lilly   \n",
       "40  {'href': 'https://nypost.com', 'title': 'New Y...  Ozempic Eli Lilly   \n",
       "36  {'href': 'https://english.elpais.com', 'title'...  Ozempic Eli Lilly   \n",
       "15  {'href': 'https://www.fiercepharma.com', 'titl...  Ozempic Eli Lilly   \n",
       "33  {'href': 'https://www.morningstar.com', 'title...  Ozempic Eli Lilly   \n",
       "\n",
       "               query end date  published datetime published date str  \\\n",
       "34 2023-12-07 02:38:25.798191 2023-12-02 11:00:39         2023-12-02   \n",
       "40 2023-12-07 02:38:25.798191 2023-11-06 08:00:00         2023-11-06   \n",
       "36 2023-12-07 02:38:25.798191 2023-10-24 07:00:00         2023-10-24   \n",
       "15 2023-12-07 02:38:25.798191 2023-11-22 08:00:00         2023-11-22   \n",
       "33 2023-12-07 02:38:25.798191 2023-12-01 15:20:00         2023-12-01   \n",
       "\n",
       "                                         article text  \\\n",
       "34  On Friday, Pfizer announced that it’s dropping...   \n",
       "40  An Australian woman who took Ozempic to shed a...   \n",
       "36  Starry-eyed venture capitalists love to talk a...   \n",
       "15  Unable to scale up its manufacturing fast enou...   \n",
       "33  By Ciara Linnane\\n\\nPfizer says it will not mo...   \n",
       "\n",
       "                                         article html  \\\n",
       "34  <!DOCTYPE html><html class=\"page article-page\"...   \n",
       "40  <!doctype html>\\n<html lang=\"en-US\">\\n\\n<head ...   \n",
       "36  <!DOCTYPE html><html lang=\"en-us\"><head><scrip...   \n",
       "15  <!DOCTYPE html>\\n<html lang=\"en\" dir=\"ltr\" pre...   \n",
       "33  <!doctype html>\\n<html data-n-head-ssr lang=\"e...   \n",
       "\n",
       "                                      article summary  \\\n",
       "34  On Friday, Pfizer announced that it’s dropping...   \n",
       "40  Intestinal blockage is called “ileus” — the FD...   \n",
       "36  New anti-obesity drugs have the potential to t...   \n",
       "15  Unable to scale up its manufacturing fast enou...   \n",
       "33  The stock was on track for its biggest one-day...   \n",
       "\n",
       "                                     article keywords  sentiment_score  \\\n",
       "34  [pills, catch, ozempic, struggles, experienced...                8   \n",
       "40  [daughters, drug, shouldnt, woman, minutes, 60...                8   \n",
       "36  [medical, antiobesity, ozempic, mounjaro, reve...                8   \n",
       "15  [shortage, drug, production, boost, quarter, o...                8   \n",
       "33  [drug, dow, danuglipron, jones, eli, halting, ...                7   \n",
       "\n",
       "                                sentiment_explanation  \\\n",
       "34  The article portrays a negative sentiment towa...   \n",
       "40  The sentiment negativity score for the article...   \n",
       "36  The article discusses potential negative impac...   \n",
       "15  The article contains several negative claims a...   \n",
       "33  The sentiment negativity score for the article...   \n",
       "\n",
       "                                      negative_claims  \n",
       "34  - Pfizer is dropping development of an experim...  \n",
       "40  - Use of Ozempic led to the death of a woman\\n...  \n",
       "36  - New anti-obesity drugs have the potential to...  \n",
       "15  Novo Nordisk facing shortage of Victoza\\nReduc...  \n",
       "33  - Pfizer's stock tumbled 6%\\n- Pfizer's stock ...  "
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<table>\n",
       "<thead>\n",
       "<tr><th style=\"text-align: right;\">  </th><th>title                                                                                                       </th><th>description                                                                                                </th><th>published date  </th><th>url                                                                                                                                                                                                                                                                                                                                                                                                                                                                    </th><th>publisher                                                        </th><th>query            </th><th>query end date            </th><th>published datetime  </th><th>published date str  </th><th>article summary  </th><th>article keywords  </th><th style=\"text-align: right;\">  sentiment_score</th><th>sentiment_explanation                                                                                                                                                                                          </th><th>negative_claims  </th></tr>\n",
       "</thead>\n",
       "<tbody>\n",
       "<tr><td style=\"text-align: right;\">34</td><td>Pfizer struggles to catch up to Ozempic, Wegovy with weight-loss pill - Los Angeles Times                   </td><td>Pfizer struggles to catch up to Ozempic, Wegovy with weight-loss pill  Los Angeles Times                   </td><td>2023-12-02      </td><td>https://news.google.com/rss/articles/CBMidmh0dHBzOi8vd3d3LmxhdGltZXMuY29tL2J1c2luZXNzL3N0b3J5LzIwMjMtMTItMDIvcGZpemVyLXN0cnVnZ2xlcy10by1jYXRjaC11cC10by1vemVtcGljLXdlZ292eS13aXRoLXdlaWdodC1sb3NzLXBpbGzSAQA?oc=5&amp;hl=en-US&amp;gl=US&amp;ceid=US:en                                                                                                                                                                                                                            </td><td>{&#x27;href&#x27;: &#x27;https://www.latimes.com&#x27;, &#x27;title&#x27;: &#x27;Los Angeles Times&#x27;}</td><td>Ozempic Eli Lilly</td><td>2023-12-07 02:38:25.798191</td><td>2023-12-02 11:00:39 </td><td>2023-12-02          </td><td>On Friday, Pfizer announced that it’s dropping development of an experimental weight-loss pill after patients experienced uncomfortable side effects in clinical trials.\n",
       "A pill has been widely viewed as a way for new players to make inroads in a frenzied new weight-loss market dominated by the makers of injectable Ozempic and Mounjaro.\n",
       "Some drugs earlier in development rival a level of weight loss only thought possible with bariatric surgery.\n",
       "A pill might persuade more patients to take weight-loss drugs.\n",
       "Rybelsus, Novo’s pill version of the diabetes shot Ozempic that’s often used for weight loss, is available at $936 for a one-month supply.                  </td><td>[&#x27;pills&#x27; &#x27;catch&#x27; &#x27;ozempic&#x27; &#x27;struggles&#x27; &#x27;experienced&#x27; &#x27;pfizer&#x27; &#x27;loss&#x27;\n",
       " &#x27;pill&#x27; &#x27;drugs&#x27; &#x27;patients&#x27; &#x27;weight&#x27; &#x27;wegovy&#x27; &#x27;rival&#x27; &#x27;weightloss&#x27;]                   </td><td style=\"text-align: right;\">                8</td><td>The article portrays a negative sentiment towards Pfizer&#x27;s struggle to develop an effective weight-loss pill, highlighting the challenges, side effects, and limitations compared to existing injectable drugs.</td><td>- Pfizer is dropping development of an experimental weight-loss pill due to uncomfortable side effects in clinical trials.\n",
       "- Pfizer&#x27;s weight-loss pill, danuglipron, resulted in high rates of nausea, vomiting, and diarrhea in patients, making it unsuitable for twice-daily use.\n",
       "- Pills like Pfizer&#x27;s small molecule drugs may pose a higher risk for side effects, including the risk of liver toxicity.\n",
       "- Pfizer&#x27;s pill development is far behind in comparison to the existing injectable weight-loss drugs, struggling to match their efficacy and formulation.                  </td></tr>\n",
       "<tr><td style=\"text-align: right;\">40</td><td>Woman dies after taking Ozempic to slim down for daughter&#x27;s wedding: &#x27;She shouldn&#x27;t be gone&#x27; - New York Post</td><td>Woman dies after taking Ozempic to slim down for daughter&#x27;s wedding: &#x27;She shouldn&#x27;t be gone&#x27;  New York Post</td><td>2023-11-06      </td><td>https://news.google.com/rss/articles/CBMiYWh0dHBzOi8vbnlwb3N0LmNvbS8yMDIzLzExLzA2L2xpZmVzdHlsZS93b21hbi1kaWVzLWFmdGVyLXRha2luZy1vemVtcGljLXRvLXNsaW0tZG93bi1mb3Itd2VkZGluZy_SAWVodHRwczovL255cG9zdC5jb20vMjAyMy8xMS8wNi9saWZlc3R5bGUvd29tYW4tZGllcy1hZnRlci10YWtpbmctb3plbXBpYy10by1zbGltLWRvd24tZm9yLXdlZGRpbmcvYW1wLw?oc=5&amp;hl=en-US&amp;gl=US&amp;ceid=US:en                                                                                                                 </td><td>{&#x27;href&#x27;: &#x27;https://nypost.com&#x27;, &#x27;title&#x27;: &#x27;New York Post&#x27;}         </td><td>Ozempic Eli Lilly</td><td>2023-12-07 02:38:25.798191</td><td>2023-11-06 08:00:00 </td><td>2023-11-06          </td><td>Intestinal blockage is called “ileus” — the FDA received 18 reports of it in people taking Ozempic as of late September.\n",
       "60 Minutes Australia“She had a little bit of brown stuff coming out of her mouth, and I realized she wasn’t breathing and started doing CPR,” Roy Webster recounted to “60 Minutes Australia” last week.\n",
       "6 On Jan. 16, just a few months before her daughter’s wedding, Webster’s husband allegedly found her unconscious with a brown liquid seeping out of her mouth.\n",
       "60 Minutes Australia“If I knew that could happen, she wouldn’t have been taking it,” the grieving husband insisted.\n",
       "60 Minutes AustraliaGastroparesis is just one of many side effects that have been reported, including “Ozempic finger,” “Ozempic burp,” “Ozempic butt,” “Ozempic face” and weird dreams about celebrities.                  </td><td>[&#x27;daughters&#x27; &#x27;drug&#x27; &#x27;shouldnt&#x27; &#x27;woman&#x27; &#x27;minutes&#x27; &#x27;60&#x27; &#x27;ozempic&#x27; &#x27;dies&#x27;\n",
       " &#x27;webster&#x27; &#x27;worth&#x27; &#x27;husband&#x27; &#x27;gastrointestinal&#x27; &#x27;taking&#x27; &#x27;slim&#x27; &#x27;gone&#x27;\n",
       " &#x27;wedding&#x27;]                   </td><td style=\"text-align: right;\">                8</td><td>The sentiment negativity score for the article is 8, indicating a very negative sentiment.                                                                                                                     </td><td>- Use of Ozempic led to the death of a woman\n",
       "- Reports of gastrointestinal illness and intestinal blockage associated with Ozempic usage\n",
       "- Manufacturer awareness of problems related to the drug after its release\n",
       "- Lawsuits and claims alleging severe gastrointestinal problems and injuries from weight-loss drugs\n",
       "- FDA update acknowledging complaints of blocked intestines and thousands of reports of gastrointestinal troubles from Ozempic users\n",
       "- Concerns about long-term effects and misuse of Ozempic and similar medications                  </td></tr>\n",
       "<tr><td style=\"text-align: right;\">36</td><td>Anti-obesity drugs Ozempic and Mounjaro can shrink more than patients - EL PAÍS USA                         </td><td>Anti-obesity drugs Ozempic and Mounjaro can shrink more than patients  EL PAÍS USA                         </td><td>2023-10-24      </td><td>https://news.google.com/rss/articles/CBMihQFodHRwczovL2VuZ2xpc2guZWxwYWlzLmNvbS9lY29ub215LWFuZC1idXNpbmVzcy8yMDIzLTEwLTI0L2FudGktb2Jlc2l0eS1kcnVncy1vemVtcGljLWFuZC1tb3VuamFyby1jYW4tc2hyaW5rLW1vcmUtdGhhbi1wYXRpZW50cy5odG1s0gGUAWh0dHBzOi8vZW5nbGlzaC5lbHBhaXMuY29tL2Vjb25vbXktYW5kLWJ1c2luZXNzLzIwMjMtMTAtMjQvYW50aS1vYmVzaXR5LWRydWdzLW96ZW1waWMtYW5kLW1vdW5qYXJvLWNhbi1zaHJpbmstbW9yZS10aGFuLXBhdGllbnRzLmh0bWw_b3V0cHV0VHlwZT1hbXA?oc=5&amp;hl=en-US&amp;gl=US&amp;ceid=US:en</td><td>{&#x27;href&#x27;: &#x27;https://english.elpais.com&#x27;, &#x27;title&#x27;: &#x27;EL PAÍS USA&#x27;}   </td><td>Ozempic Eli Lilly</td><td>2023-12-07 02:38:25.798191</td><td>2023-10-24 07:00:00 </td><td>2023-10-24          </td><td>New anti-obesity drugs have the potential to transform public health, while obliterating demand for products and services from the medical, food and fitness industries.\n",
       "Drugs developed by Novo Nordisk and Eli Lilly appear to be the first truly effective diet treatments.\n",
       "In one clinical trial, patients taking Eli Lilly’s soon-to-be-launched weight-loss drug lost about 50 pounds (23 kg).\n",
       "Last year, Novo sold nearly $2.5 billion worth of Wegovy and Ozempic, its treatment for people with diabetes.\n",
       "Lilly, whose diabetes treatment is called Mounjaro, has seen its market value nearly double to more than $500 billion in under 18 months.                  </td><td>[&#x27;medical&#x27; &#x27;antiobesity&#x27; &#x27;ozempic&#x27; &#x27;mounjaro&#x27; &#x27;revenue&#x27; &#x27;treatment&#x27; &#x27;novo&#x27;\n",
       " &#x27;drugs&#x27; &#x27;patients&#x27; &#x27;billion&#x27; &#x27;obesity&#x27; &#x27;health&#x27; &#x27;shrink&#x27; &#x27;nearly&#x27;]                   </td><td style=\"text-align: right;\">                8</td><td>The article discusses potential negative impacts on various industries and businesses due to the introduction of new anti-obesity drugs, leading to a significant sentiment negativity score.                  </td><td>- New anti-obesity drugs have the potential to obliterate demand for products and services from the medical, food, and fitness industries.\n",
       "- The article mentions the potential adverse effects on companies such as Nestlé, Mondelez International, McDonald’s, Burger King, Yum Brands, ResMed, Inspire Medical Systems, Zimmer Biomet, Smith+Nephew, and WW International.\n",
       "- Concerns about the reduced demand for joint replacements and weight management treatments are raised.\n",
       "- Potential negative impact on the alcohol and gambling industries is discussed.                  </td></tr>\n",
       "<tr><td style=\"text-align: right;\">15</td><td>Novo Nordisk to reduce supply of Victoza to make more Ozempic - FiercePharma                                </td><td>Novo Nordisk to reduce supply of Victoza to make more Ozempic  FiercePharma                                </td><td>2023-11-22      </td><td>https://news.google.com/rss/articles/CBMicmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FkZHJlc3Mtc2hvcnRhZ2Utbm92by1ub3JkaXNrLXdpbGwtY3V0LXByb2R1Y3Rpb24tdmljdG96YS1ib29zdC1zdXBwbHktb3plbXBpY9IBAA?oc=5&amp;hl=en-US&amp;gl=US&amp;ceid=US:en                                                                                                                                                                                                                                 </td><td>{&#x27;href&#x27;: &#x27;https://www.fiercepharma.com&#x27;, &#x27;title&#x27;: &#x27;FiercePharma&#x27;}</td><td>Ozempic Eli Lilly</td><td>2023-12-07 02:38:25.798191</td><td>2023-11-22 08:00:00 </td><td>2023-11-22          </td><td>Unable to scale up its manufacturing fast enough to meet the spiraling demand for its GLP-1 weight loss products, Novo Nordisk is employing a new strategy—reducing production of diabetes drug Victoza to make more Ozempic.\n",
       "While Victoza (liraglutide) and Ozempic (semaglutide) are both GLP-1 drugs, the former—which was originally approved in 2010—is not used for weight loss.\n",
       "Novo Nordisk will limit the supply of starter doses of Ozempic (0.25 mg) to help curb the initiation of new patients, the company said.\n",
       "Lilly says that by the end of this year, it will have twice the capacity as it had at the start of the year to produce its weight loss products.\n",
       "In the third quarter, Ozempic sales reached $3.3 billion, while Novo’s obesity treatment Wegovy—which is simply the same drug at a higher dose—rung up $1.4 billion in sales.                  </td><td>[&#x27;shortage&#x27; &#x27;drug&#x27; &#x27;production&#x27; &#x27;boost&#x27; &#x27;quarter&#x27; &#x27;ozempic&#x27; &#x27;cut&#x27; &#x27;novo&#x27;\n",
       " &#x27;sales&#x27; &#x27;supply&#x27; &#x27;loss&#x27; &#x27;weight&#x27; &#x27;billion&#x27; &#x27;nordisk&#x27; &#x27;victoza&#x27; &#x27;address&#x27;]                   </td><td style=\"text-align: right;\">                8</td><td>The article contains several negative claims about the shortage of diabetes drug Victoza, intermittent shortages of Ozempic, and the overwhelming demand causing limitations on its use.                       </td><td>Novo Nordisk facing shortage of Victoza\n",
       "Reduction in production of Victoza to make more Ozempic causing supply issues\n",
       "Intermittent shortages of Ozempic expected to persist throughout 2024\n",
       "Overwhelming demand for Ozempic leading to limitations on use in some countries                  </td></tr>\n",
       "<tr><td style=\"text-align: right;\">33</td><td>Pfizer&#x27;s stock falls 6% after halting trial of obesity drug due to side ... - Morningstar                   </td><td>Pfizer&#x27;s stock falls 6% after halting trial of obesity drug due to side ...  Morningstar                   </td><td>2023-12-01      </td><td>https://news.google.com/rss/articles/CBMihgFodHRwczovL3d3dy5tb3JuaW5nc3Rhci5jb20vbmV3cy9tYXJrZXR3YXRjaC8yMDIzMTIwMTM0Ny9wZml6ZXJzLXN0b2NrLWZhbGxzLTYtYWZ0ZXItaGFsdGluZy10cmlhbC1vZi1vYmVzaXR5LWRydWctZHVlLXRvLXNpZGUtZWZmZWN0c9IBAA?oc=5&amp;hl=en-US&amp;gl=US&amp;ceid=US:en                                                                                                                                                                                                     </td><td>{&#x27;href&#x27;: &#x27;https://www.morningstar.com&#x27;, &#x27;title&#x27;: &#x27;Morningstar&#x27;}  </td><td>Ozempic Eli Lilly</td><td>2023-12-07 02:38:25.798191</td><td>2023-12-01 15:20:00 </td><td>2023-12-01          </td><td>The stock was on track for its biggest one-day percentage decline since June 11, 2020, when it fell 7.3%, according to Dow Jones Market Data.\n",
       "Pfizer&#x27;s stock has fallen 44% in the year to date, while the S&amp;P 500 has gained 19%.\n",
       "Both Mounjaro and Ozempic have U.S. regulatory approval for treatment of Type 2 diabetes - not weight loss.\n",
       "Read now: Medicare&#x27;s exclusion of weight-loss drug coverage under fire-Ciara LinnaneThis content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.\n",
       "(END) Dow Jones Newswires12-01-23 1020ETCopyright (c) 2023 Dow Jones &amp; Company, Inc.                  </td><td>[&#x27;drug&#x27; &#x27;dow&#x27; &#x27;danuglipron&#x27; &#x27;jones&#x27; &#x27;eli&#x27; &#x27;halting&#x27; &#x27;falls&#x27; &#x27;ozempic&#x27;\n",
       " &#x27;study&#x27; &#x27;mounjaro&#x27; &#x27;effects&#x27; &#x27;stock&#x27; &#x27;formulation&#x27; &#x27;trial&#x27; &#x27;obesity&#x27;\n",
       " &#x27;weight&#x27; &#x27;loss&#x27; &#x27;pfizers&#x27;]                   </td><td style=\"text-align: right;\">                7</td><td>The sentiment negativity score for the article is 7, indicating a moderately negative sentiment.                                                                                                               </td><td>- Pfizer&#x27;s stock tumbled 6%\n",
       "- Pfizer&#x27;s stock has fallen 44% in the year to date\n",
       "- High discontinuation rates, greater than 50%, for the weight-loss drug\n",
       "- Pfizer terminated the development of a similar treatment called lotiglipron after early clinical data showed potential for elevated liver enzymes                  </td></tr>\n",
       "</tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "'<table>\\n<thead>\\n<tr><th style=\"text-align: right;\">  </th><th>title                                                                                                       </th><th>description                                                                                                </th><th>published date  </th><th>url                                                                                                                                                                                                                                                                                                                                                                                                                                                                    </th><th>publisher                                                        </th><th>query            </th><th>query end date            </th><th>published datetime  </th><th>published date str  </th><th>article summary  </th><th>article keywords  </th><th style=\"text-align: right;\">  sentiment_score</th><th>sentiment_explanation                                                                                                                                                                                          </th><th>negative_claims  </th></tr>\\n</thead>\\n<tbody>\\n<tr><td style=\"text-align: right;\">34</td><td>Pfizer struggles to catch up to Ozempic, Wegovy with weight-loss pill - Los Angeles Times                   </td><td>Pfizer struggles to catch up to Ozempic, Wegovy with weight-loss pill  Los Angeles Times                   </td><td>2023-12-02      </td><td>https://news.google.com/rss/articles/CBMidmh0dHBzOi8vd3d3LmxhdGltZXMuY29tL2J1c2luZXNzL3N0b3J5LzIwMjMtMTItMDIvcGZpemVyLXN0cnVnZ2xlcy10by1jYXRjaC11cC10by1vemVtcGljLXdlZ292eS13aXRoLXdlaWdodC1sb3NzLXBpbGzSAQA?oc=5&amp;hl=en-US&amp;gl=US&amp;ceid=US:en                                                                                                                                                                                                                            </td><td>{&#x27;href&#x27;: &#x27;https://www.latimes.com&#x27;, &#x27;title&#x27;: &#x27;Los Angeles Times&#x27;}</td><td>Ozempic Eli Lilly</td><td>2023-12-07 02:38:25.798191</td><td>2023-12-02 11:00:39 </td><td>2023-12-02          </td><td>On Friday, Pfizer announced that it’s dropping development of an experimental weight-loss pill after patients experienced uncomfortable side effects in clinical trials.\\nA pill has been widely viewed as a way for new players to make inroads in a frenzied new weight-loss market dominated by the makers of injectable Ozempic and Mounjaro.\\nSome drugs earlier in development rival a level of weight loss only thought possible with bariatric surgery.\\nA pill might persuade more patients to take weight-loss drugs.\\nRybelsus, Novo’s pill version of the diabetes shot Ozempic that’s often used for weight loss, is available at $936 for a one-month supply.                  </td><td>[&#x27;pills&#x27; &#x27;catch&#x27; &#x27;ozempic&#x27; &#x27;struggles&#x27; &#x27;experienced&#x27; &#x27;pfizer&#x27; &#x27;loss&#x27;\\n &#x27;pill&#x27; &#x27;drugs&#x27; &#x27;patients&#x27; &#x27;weight&#x27; &#x27;wegovy&#x27; &#x27;rival&#x27; &#x27;weightloss&#x27;]                   </td><td style=\"text-align: right;\">                8</td><td>The article portrays a negative sentiment towards Pfizer&#x27;s struggle to develop an effective weight-loss pill, highlighting the challenges, side effects, and limitations compared to existing injectable drugs.</td><td>- Pfizer is dropping development of an experimental weight-loss pill due to uncomfortable side effects in clinical trials.\\n- Pfizer&#x27;s weight-loss pill, danuglipron, resulted in high rates of nausea, vomiting, and diarrhea in patients, making it unsuitable for twice-daily use.\\n- Pills like Pfizer&#x27;s small molecule drugs may pose a higher risk for side effects, including the risk of liver toxicity.\\n- Pfizer&#x27;s pill development is far behind in comparison to the existing injectable weight-loss drugs, struggling to match their efficacy and formulation.                  </td></tr>\\n<tr><td style=\"text-align: right;\">40</td><td>Woman dies after taking Ozempic to slim down for daughter&#x27;s wedding: &#x27;She shouldn&#x27;t be gone&#x27; - New York Post</td><td>Woman dies after taking Ozempic to slim down for daughter&#x27;s wedding: &#x27;She shouldn&#x27;t be gone&#x27;  New York Post</td><td>2023-11-06      </td><td>https://news.google.com/rss/articles/CBMiYWh0dHBzOi8vbnlwb3N0LmNvbS8yMDIzLzExLzA2L2xpZmVzdHlsZS93b21hbi1kaWVzLWFmdGVyLXRha2luZy1vemVtcGljLXRvLXNsaW0tZG93bi1mb3Itd2VkZGluZy_SAWVodHRwczovL255cG9zdC5jb20vMjAyMy8xMS8wNi9saWZlc3R5bGUvd29tYW4tZGllcy1hZnRlci10YWtpbmctb3plbXBpYy10by1zbGltLWRvd24tZm9yLXdlZGRpbmcvYW1wLw?oc=5&amp;hl=en-US&amp;gl=US&amp;ceid=US:en                                                                                                                 </td><td>{&#x27;href&#x27;: &#x27;https://nypost.com&#x27;, &#x27;title&#x27;: &#x27;New York Post&#x27;}         </td><td>Ozempic Eli Lilly</td><td>2023-12-07 02:38:25.798191</td><td>2023-11-06 08:00:00 </td><td>2023-11-06          </td><td>Intestinal blockage is called “ileus” — the FDA received 18 reports of it in people taking Ozempic as of late September.\\n60 Minutes Australia“She had a little bit of brown stuff coming out of her mouth, and I realized she wasn’t breathing and started doing CPR,” Roy Webster recounted to “60 Minutes Australia” last week.\\n6 On Jan. 16, just a few months before her daughter’s wedding, Webster’s husband allegedly found her unconscious with a brown liquid seeping out of her mouth.\\n60 Minutes Australia“If I knew that could happen, she wouldn’t have been taking it,” the grieving husband insisted.\\n60 Minutes AustraliaGastroparesis is just one of many side effects that have been reported, including “Ozempic finger,” “Ozempic burp,” “Ozempic butt,” “Ozempic face” and weird dreams about celebrities.                  </td><td>[&#x27;daughters&#x27; &#x27;drug&#x27; &#x27;shouldnt&#x27; &#x27;woman&#x27; &#x27;minutes&#x27; &#x27;60&#x27; &#x27;ozempic&#x27; &#x27;dies&#x27;\\n &#x27;webster&#x27; &#x27;worth&#x27; &#x27;husband&#x27; &#x27;gastrointestinal&#x27; &#x27;taking&#x27; &#x27;slim&#x27; &#x27;gone&#x27;\\n &#x27;wedding&#x27;]                   </td><td style=\"text-align: right;\">                8</td><td>The sentiment negativity score for the article is 8, indicating a very negative sentiment.                                                                                                                     </td><td>- Use of Ozempic led to the death of a woman\\n- Reports of gastrointestinal illness and intestinal blockage associated with Ozempic usage\\n- Manufacturer awareness of problems related to the drug after its release\\n- Lawsuits and claims alleging severe gastrointestinal problems and injuries from weight-loss drugs\\n- FDA update acknowledging complaints of blocked intestines and thousands of reports of gastrointestinal troubles from Ozempic users\\n- Concerns about long-term effects and misuse of Ozempic and similar medications                  </td></tr>\\n<tr><td style=\"text-align: right;\">36</td><td>Anti-obesity drugs Ozempic and Mounjaro can shrink more than patients - EL PAÍS USA                         </td><td>Anti-obesity drugs Ozempic and Mounjaro can shrink more than patients  EL PAÍS USA                         </td><td>2023-10-24      </td><td>https://news.google.com/rss/articles/CBMihQFodHRwczovL2VuZ2xpc2guZWxwYWlzLmNvbS9lY29ub215LWFuZC1idXNpbmVzcy8yMDIzLTEwLTI0L2FudGktb2Jlc2l0eS1kcnVncy1vemVtcGljLWFuZC1tb3VuamFyby1jYW4tc2hyaW5rLW1vcmUtdGhhbi1wYXRpZW50cy5odG1s0gGUAWh0dHBzOi8vZW5nbGlzaC5lbHBhaXMuY29tL2Vjb25vbXktYW5kLWJ1c2luZXNzLzIwMjMtMTAtMjQvYW50aS1vYmVzaXR5LWRydWdzLW96ZW1waWMtYW5kLW1vdW5qYXJvLWNhbi1zaHJpbmstbW9yZS10aGFuLXBhdGllbnRzLmh0bWw_b3V0cHV0VHlwZT1hbXA?oc=5&amp;hl=en-US&amp;gl=US&amp;ceid=US:en</td><td>{&#x27;href&#x27;: &#x27;https://english.elpais.com&#x27;, &#x27;title&#x27;: &#x27;EL PAÍS USA&#x27;}   </td><td>Ozempic Eli Lilly</td><td>2023-12-07 02:38:25.798191</td><td>2023-10-24 07:00:00 </td><td>2023-10-24          </td><td>New anti-obesity drugs have the potential to transform public health, while obliterating demand for products and services from the medical, food and fitness industries.\\nDrugs developed by Novo Nordisk and Eli Lilly appear to be the first truly effective diet treatments.\\nIn one clinical trial, patients taking Eli Lilly’s soon-to-be-launched weight-loss drug lost about 50 pounds (23 kg).\\nLast year, Novo sold nearly $2.5 billion worth of Wegovy and Ozempic, its treatment for people with diabetes.\\nLilly, whose diabetes treatment is called Mounjaro, has seen its market value nearly double to more than $500 billion in under 18 months.                  </td><td>[&#x27;medical&#x27; &#x27;antiobesity&#x27; &#x27;ozempic&#x27; &#x27;mounjaro&#x27; &#x27;revenue&#x27; &#x27;treatment&#x27; &#x27;novo&#x27;\\n &#x27;drugs&#x27; &#x27;patients&#x27; &#x27;billion&#x27; &#x27;obesity&#x27; &#x27;health&#x27; &#x27;shrink&#x27; &#x27;nearly&#x27;]                   </td><td style=\"text-align: right;\">                8</td><td>The article discusses potential negative impacts on various industries and businesses due to the introduction of new anti-obesity drugs, leading to a significant sentiment negativity score.                  </td><td>- New anti-obesity drugs have the potential to obliterate demand for products and services from the medical, food, and fitness industries.\\n- The article mentions the potential adverse effects on companies such as Nestlé, Mondelez International, McDonald’s, Burger King, Yum Brands, ResMed, Inspire Medical Systems, Zimmer Biomet, Smith+Nephew, and WW International.\\n- Concerns about the reduced demand for joint replacements and weight management treatments are raised.\\n- Potential negative impact on the alcohol and gambling industries is discussed.                  </td></tr>\\n<tr><td style=\"text-align: right;\">15</td><td>Novo Nordisk to reduce supply of Victoza to make more Ozempic - FiercePharma                                </td><td>Novo Nordisk to reduce supply of Victoza to make more Ozempic  FiercePharma                                </td><td>2023-11-22      </td><td>https://news.google.com/rss/articles/CBMicmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FkZHJlc3Mtc2hvcnRhZ2Utbm92by1ub3JkaXNrLXdpbGwtY3V0LXByb2R1Y3Rpb24tdmljdG96YS1ib29zdC1zdXBwbHktb3plbXBpY9IBAA?oc=5&amp;hl=en-US&amp;gl=US&amp;ceid=US:en                                                                                                                                                                                                                                 </td><td>{&#x27;href&#x27;: &#x27;https://www.fiercepharma.com&#x27;, &#x27;title&#x27;: &#x27;FiercePharma&#x27;}</td><td>Ozempic Eli Lilly</td><td>2023-12-07 02:38:25.798191</td><td>2023-11-22 08:00:00 </td><td>2023-11-22          </td><td>Unable to scale up its manufacturing fast enough to meet the spiraling demand for its GLP-1 weight loss products, Novo Nordisk is employing a new strategy—reducing production of diabetes drug Victoza to make more Ozempic.\\nWhile Victoza (liraglutide) and Ozempic (semaglutide) are both GLP-1 drugs, the former—which was originally approved in 2010—is not used for weight loss.\\nNovo Nordisk will limit the supply of starter doses of Ozempic (0.25 mg) to help curb the initiation of new patients, the company said.\\nLilly says that by the end of this year, it will have twice the capacity as it had at the start of the year to produce its weight loss products.\\nIn the third quarter, Ozempic sales reached $3.3 billion, while Novo’s obesity treatment Wegovy—which is simply the same drug at a higher dose—rung up $1.4 billion in sales.                  </td><td>[&#x27;shortage&#x27; &#x27;drug&#x27; &#x27;production&#x27; &#x27;boost&#x27; &#x27;quarter&#x27; &#x27;ozempic&#x27; &#x27;cut&#x27; &#x27;novo&#x27;\\n &#x27;sales&#x27; &#x27;supply&#x27; &#x27;loss&#x27; &#x27;weight&#x27; &#x27;billion&#x27; &#x27;nordisk&#x27; &#x27;victoza&#x27; &#x27;address&#x27;]                   </td><td style=\"text-align: right;\">                8</td><td>The article contains several negative claims about the shortage of diabetes drug Victoza, intermittent shortages of Ozempic, and the overwhelming demand causing limitations on its use.                       </td><td>Novo Nordisk facing shortage of Victoza\\nReduction in production of Victoza to make more Ozempic causing supply issues\\nIntermittent shortages of Ozempic expected to persist throughout 2024\\nOverwhelming demand for Ozempic leading to limitations on use in some countries                  </td></tr>\\n<tr><td style=\"text-align: right;\">33</td><td>Pfizer&#x27;s stock falls 6% after halting trial of obesity drug due to side ... - Morningstar                   </td><td>Pfizer&#x27;s stock falls 6% after halting trial of obesity drug due to side ...  Morningstar                   </td><td>2023-12-01      </td><td>https://news.google.com/rss/articles/CBMihgFodHRwczovL3d3dy5tb3JuaW5nc3Rhci5jb20vbmV3cy9tYXJrZXR3YXRjaC8yMDIzMTIwMTM0Ny9wZml6ZXJzLXN0b2NrLWZhbGxzLTYtYWZ0ZXItaGFsdGluZy10cmlhbC1vZi1vYmVzaXR5LWRydWctZHVlLXRvLXNpZGUtZWZmZWN0c9IBAA?oc=5&amp;hl=en-US&amp;gl=US&amp;ceid=US:en                                                                                                                                                                                                     </td><td>{&#x27;href&#x27;: &#x27;https://www.morningstar.com&#x27;, &#x27;title&#x27;: &#x27;Morningstar&#x27;}  </td><td>Ozempic Eli Lilly</td><td>2023-12-07 02:38:25.798191</td><td>2023-12-01 15:20:00 </td><td>2023-12-01          </td><td>The stock was on track for its biggest one-day percentage decline since June 11, 2020, when it fell 7.3%, according to Dow Jones Market Data.\\nPfizer&#x27;s stock has fallen 44% in the year to date, while the S&amp;P 500 has gained 19%.\\nBoth Mounjaro and Ozempic have U.S. regulatory approval for treatment of Type 2 diabetes - not weight loss.\\nRead now: Medicare&#x27;s exclusion of weight-loss drug coverage under fire-Ciara LinnaneThis content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.\\n(END) Dow Jones Newswires12-01-23 1020ETCopyright (c) 2023 Dow Jones &amp; Company, Inc.                  </td><td>[&#x27;drug&#x27; &#x27;dow&#x27; &#x27;danuglipron&#x27; &#x27;jones&#x27; &#x27;eli&#x27; &#x27;halting&#x27; &#x27;falls&#x27; &#x27;ozempic&#x27;\\n &#x27;study&#x27; &#x27;mounjaro&#x27; &#x27;effects&#x27; &#x27;stock&#x27; &#x27;formulation&#x27; &#x27;trial&#x27; &#x27;obesity&#x27;\\n &#x27;weight&#x27; &#x27;loss&#x27; &#x27;pfizers&#x27;]                   </td><td style=\"text-align: right;\">                7</td><td>The sentiment negativity score for the article is 7, indicating a moderately negative sentiment.                                                                                                               </td><td>- Pfizer&#x27;s stock tumbled 6%\\n- Pfizer&#x27;s stock has fallen 44% in the year to date\\n- High discontinuation rates, greater than 50%, for the weight-loss drug\\n- Pfizer terminated the development of a similar treatment called lotiglipron after early clinical data showed potential for elevated liver enzymes                  </td></tr>\\n</tbody>\\n</table>'"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "print_df(df.head(5).drop(columns=['article text','article html']))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "my_venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.13"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
